Whole Body Health Sale

IceCure reports success in trial for lung cancer treatment


Globes (Tel Aviv)

11-14-13

Nov. 12--IceCure Ltd. (TASE: ICCM) has announced that, as part of a clinical trial at Kameda Medical Center in Japan, two lung cancer patients in Japan were successfully treated with the company's IceSense3 cryotherapy system. Kameda Medical Center is fully funding the study.

IceCure's system already destroys benign tumors, in addition to a clinical trial in the US for the treatment of breast cancer tumors, and now the clinical trial in Japan. Lung cancer is the most frequent cause of death among cancer patients, and IceCure's successful entry into this market greatly increases its business potential.

IceCure president and CEO Hezi Himelfarb said, "We're pleased at the success in destroying lung cancer tumors because use of our cryoablation platform could open to us a potential market of hundreds of thousands of new cases in the US alone. Treatment with IceCure's system, which is a minimally invasive procedure, has clear advantages over complicated and expensive surgical solutions for excising tumors, which involve hospital stays, surgery, and prolonged recovery. We believe that further success in the breast cancer clinical trial in the US and the lung cancer clinical trial in Japan positions IceCure in a good place and paves the way to participating in these opportunities."

After the trial is completed and the results are analyzed, IceCure will examine the extent of its involvement in the treatment of lung cancer by cryoablation. A preclinical trial on animals at Kameda Medical Center found it more effective compared with other cryoablation methods.

Studies in the US have found that lung cancer is the biggest killer of all types of cancer in both men and women, accounting for more deaths than the next three cancers (colon cancer, breast cancer, and prostate cancer) combined.

___

(c)2013 the Globes (Tel Aviv, Israel)

Visit the Globes (Tel Aviv, Israel) at www.globes.co.il/serveen/globes/nodeview.asp?fid=942

Distributed by MCT Information Services

Copyright Globes (Tel Aviv) 2013

Articles featured in Life Extension Daily News are derived from a variety of news sources and are provided as a service by Life Extension. These articles, while of potential interest to readers of Life Extension Daily News, do not necessarily represent the opinions nor constitute the advice of Life Extension.

  • Consumer Alerts | Learn about issues that could impact your right to obtain the nutritional supplements and/or hormones such as DHEA that you depend on.

  • LEF Forum | Life Extension hosts Forums on Supplements, Hormones, Lifestyles, Disorders/Diseases, and other areas of interest to life extensionists worldwide.

  • What's Hot | News flashes are posted here frequently to keep you up-to-date with the latest advances in health care, nutritional supplements, and longevity.

  • Legislative Action Center | Take action on important current issues featured in Life Extension magazine and our web site.

  • Events | Find out about upcoming life extension related conferences, seminars, and meetings, or view reports on past events.

  • Life Extension Update | Our periodical newsletter reports new findings in longevity, preventive medicine and disease as soon as they are discovered!

  • Multimedia Center | An information-packed collection of video and audio featuring various health topics of importance to you.

Get Your FREE Nutritional Supplement Guide